LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

18.66 -0.69

Resumen

Variación precio

24h

Actual

Mínimo

18.58

Máximo

19.48

Métricas clave

By Trading Economics

Ingresos

67M

-681K

Ventas

-2.9M

17M

P/B

Media del Sector

48.528

76.798

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+8.7% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.37%

Próximas Ganancias

8 ene 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

47M

391M

Apertura anterior

19.35

Cierre anterior

18.66

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

159 / 374 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 dic 2025, 23:50 UTC

Acciones populares

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 dic 2025, 23:20 UTC

Ganancias

Correction to Micron Logs Sales Jump Article

17 dic 2025, 23:07 UTC

Ganancias

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 dic 2025, 21:37 UTC

Ganancias

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 dic 2025, 23:53 UTC

Charlas de Mercado

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 dic 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 dic 2025, 23:06 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 dic 2025, 23:05 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 dic 2025, 23:04 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 dic 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 dic 2025, 23:02 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 dic 2025, 22:59 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 dic 2025, 22:57 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 dic 2025, 22:56 UTC

Adquisiciones, fusiones, absorciones

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 dic 2025, 22:55 UTC

Adquisiciones, fusiones, absorciones

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 dic 2025, 22:49 UTC

Charlas de Mercado

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 dic 2025, 21:58 UTC

Ganancias

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

17 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 dic 2025, 21:46 UTC

Ganancias

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 dic 2025, 21:20 UTC

Ganancias

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:10 UTC

Ganancias

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 dic 2025, 21:05 UTC

Ganancias

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 dic 2025, 21:04 UTC

Ganancias

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 dic 2025, 21:04 UTC

Ganancias

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 dic 2025, 21:03 UTC

Ganancias

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 dic 2025, 21:02 UTC

Ganancias

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 dic 2025, 21:01 UTC

Ganancias

Micron Technology 1Q Rev $13.64B >MU

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

8.7% repunte

Estimación a 12 Meses

Media 20.5 USD  8.7%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

3

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

159 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat